Focus Graphite Inc., an exploration stage company, acquires, explores, and develops mineral properties in Quebec, Canada. The company explores for graphite, iron, copper, rare-earth elements, and gold deposits. Its principal property is the Lac Knife graphite deposit that consists of 57 claims covering an area of 2,986.31 hectares located in the Côte-Nord region of Québec. The company was formerly known as Focus Metals Inc. and changed its name to Focus Graphite Inc. in May 2012. The company is based in Kingston, Canada. Focus Graphite Inc. is a subsidiary of 360House.com, Inc.
Industry, Sector and Symbol
Industry Specialized Health Services
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone613-241-4040
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date12/10/2019 (Estimated)
OptionableOptionable
Focus Graphite (CVE:FMS) Frequently Asked Questions
What is Focus Graphite's stock symbol?
Focus Graphite trades on the Canadian Venture Exchange (CVE) under the ticker symbol "FMS."
When is Focus Graphite's next earnings date?
Has Focus Graphite been receiving favorable news coverage?
News stories about FMS stock have trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Focus Graphite earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Focus Graphite.
Who are some of Focus Graphite's key competitors?
Some companies that are related to Focus Graphite include Bio-Path (BPTH), Advanzeon Solutions (CHCR), Shineco (TYHT), Cellmid (CDY), Neovasc (NVCN), Soligenix (SNGX), Microbot Medical (MBOT), Melinta Therapeutics (MLNT), Antisense Therapeutics (ANP), SugarBud Craft Growers (SUGR), Bio-Gene Technology (BGT), Avivagen (VIV), Unum Therapeutics (UMRX), Protagenic Therapeutics (PTIX) and Crescita Therapeutics (CTX).
What other stocks do shareholders of Focus Graphite own?
Who are Focus Graphite's key executives?
Focus Graphite's management team includes the folowing people:
- Mr. Gary Economo, Pres, CEO, COO & Director (Age 60)
- Ms. Judith T. Mazvihwa-MacLean CMA, MBA, MSc, BSc, Chief Financial Officer (Age 44)
- Dr. Joseph E. Doninger MSc, BSc, Director of Manufacturing & Technology
- Dr. Gordon Chiu, Chief Scientist & VP
How do I buy shares of Focus Graphite?
Shares of FMS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Focus Graphite's stock price today?
One share of FMS stock can currently be purchased for approximately C$0.02.
How big of a company is Focus Graphite?
What is Focus Graphite's official website?
How can I contact Focus Graphite?
The company can be reached via phone at 613-241-4040.
MarketBeat Community Rating for Focus Graphite (CVE FMS)
MarketBeat's community ratings are surveys of what our community members think about Focus Graphite and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
